Novartis to acquire Avidity Biosciences for $12 billion

Reuters
Oct 27, 2025
Novartis to acquire <a href="https://laohu8.com/S/RNA">Avidity Biosciences</a> for $12 billion

Oct 26 (Reuters) - Swiss drugmaker Novartis NOVN.S on Sunday said it agreed to acquire Avidity Biosciences for $12 billion.

(Reporting by Angela Christy in Bengaluru)

((AngelaChristy.M@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10